---
figid: PMC8155493__fimmu-12-662266-g002
figtitle: 'IL-36 in Infectious Diseases: Potential Target for COVID-19?'
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Hepatitis B virus
- Influenza A virus
- Coronaviridae
- Human alphaherpesvirus 1
- Severe acute respiratory syndrome-related coronavirus
- Orthomyxoviridae
- H1N1 subtype
- Zika virus
- Human alphaherpesvirus 2
- H3N2 subtype
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Streptococcus pneumoniae
- Klebsiella pneumoniae
- Citrobacter rodentium
- Cutibacterium acnes
- Mus musculus
- Cavia porcellus
- Candida albicans
- Aspergillus fumigatus
- Homo sapiens
- Sar
- synthetic construct
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8155493
filename: fimmu-12-662266-g002.jpg
figlink: /pmc/articles/PMC8155493/figure/f2/
number: F2
caption: In COVID-19 patients, SARS-CoV-2 may promote hyperinflammation in the lung
  and exacerbate tissue damage. IL-36-activated inflammatory immune cells (e.g., monocytes,
  macrophages, neutrophils and pathogenic T cells) produce IL-6, IL-1, IL-17, TNF-α
  and GM-CSF to further amplify IL-36 responses. IL-36Ra and IL-38, as the natural
  antagonistic mediators in IL-36 family might be a promising therapeutic target for
  COVID-19 via inhibiting IL-36 signaling pathway and alleviating pulmonary hyperinflammation.
papertitle: 'The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?.'
reftext: Xiaofang Wang, et al. Front Immunol. 2021;12:662266.
year: '2021'
doi: 10.3389/fimmu.2021.662266
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: IL-36 | IL-1 family | cytokine | infection | COVID-19
automl_pathway: 0.9062236
figid_alias: PMC8155493__F2
figtype: Figure
redirect_from: /figures/PMC8155493__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8155493__fimmu-12-662266-g002.html
  '@type': Dataset
  description: In COVID-19 patients, SARS-CoV-2 may promote hyperinflammation in the
    lung and exacerbate tissue damage. IL-36-activated inflammatory immune cells (e.g.,
    monocytes, macrophages, neutrophils and pathogenic T cells) produce IL-6, IL-1,
    IL-17, TNF-α and GM-CSF to further amplify IL-36 responses. IL-36Ra and IL-38,
    as the natural antagonistic mediators in IL-36 family might be a promising therapeutic
    target for COVID-19 via inhibiting IL-36 signaling pathway and alleviating pulmonary
    hyperinflammation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1F10
  - IL36RN
  - IL6
  - IL1B
  - LINC00689
  - IL17A
  - TNF
  - CSF2
  - Il36rn
  - Il6
  - Il1
  - Il17a
  - Tnf
  - Csf2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - JIL-1
  - egr
---
